BioTissue Holdings Sale to BioStem Technologies

We represented BioTissue Holdings, Inc, a leader in harnessing the unique properties of human birth tissue to facilitate regenerative healing, in the sale of its of its non-ocular Surgical and Wound Care business and license of certain platform technology to BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care. Our representation included the drafting and negotiating of license and supply agreements, as well as patent and trademark protections.